Clinical Trials in Salt Lake City

Showing 11461-11480 of 14,325 trials

Early Feasibility Study of the Percutaneous Osseointegrated Prosthesis (POP)

NCT02720159

The purpose of the clinical study is to characterize the efficacy and safety of a Percutaneous Osseointegrated Prosthesis (POP) device that can provide a satisfactory platform for direct skeletal attachment of prosthetic limbs, which includes a subdermal seal, thus allowing a proper biobarrier around the implant.

Traumatic Amputee

Encore Medical, L.P.10 participantsStarted Dec 2015

Salt Lake City, Utah, United States

COMPLETED< 1 mile

Anemia in the Elderly

NCT00640172

Eligible elderly men and women with anemia will undergo a full hematologic evaluation plus additional laboratory tests to determine the etiology of the anemia. In a subset of subjects, bone marrow aspirate and biopsies will be obtained for a planned analysis of erythroid progenitor and stem cells. Plasma; serum; and bone marrow samples will be will be compared to elderly non-anemic controls. Bone marrow samples will also be compared to non-anemic young controls (purchased).

Anemia

Stanford University343 participantsStarted Aug 2009

Palo Alto, California, United States • Stanford, California, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 316 miles

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

NCT01778049

The objective of the study is to investigate the efficacy, safety and tolerability of linagliptin 5 mg qd compared to placebo given for 24 weeks in inadequately controlled T2DM patients on empagliflozin 10 mg or 25 mg and maximum tolerated dose of metformin. The primary objective of efficacy evaluation is planned after 24 weeks of treatment. The study is designed to show superiority of the combination of empagliflozin and linagliptin over empagliflozin alone.

Diabetes Mellitus, Type 2

Boehringer Ingelheim708 participantsStarted Jan 2013

Chino, California, United States • Huntington Beach, California, United States • San Diego, California, United States +111 more locations

Early Feasibility Study of the Percutaneous Osseointegrated Prosthesis (POP)

Anemia in the Elderly

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Find Trials by Condition in Salt Lake City

Coenzyme Q10 in Huntington's Disease (HD)

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System

Cross-sectional Study for Identification and Description of Severe Asthma Patients

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Medigus Ultrasonic Surgical Endostapler (MUSE) Registry

An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects

Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia

Safety and Efficacy of EVT 101 in Treatment-Resistant Depression

Managing Recurrent Abdominal Pain

A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)